中国临床药理学杂志2023，Vol.39Issue(23)：3474-3474,1.
Nefecon胶囊治疗原发性IgA肾病患者的临床疗效和安全性评价
Efficacy and safety of a targeted-release formulation of budesonide in patients with pri-mary IgA nephropathy(NefIgArd):2-year results from a randomised phase 3 trial
引用本文复制引用
LAFAYETTE R,戴荣源..Nefecon胶囊治疗原发性IgA肾病患者的临床疗效和安全性评价[J].中国临床药理学杂志,2023,39(23):3474-3474,1.
